Your browser doesn't support javascript.
Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.
Munblit, Daniel; Nekliudov, Nikita A; Bugaeva, Polina; Blyuss, Oleg; Kislova, Maria; Listovskaya, Ekaterina; Gamirova, Aysylu; Shikhaleva, Anastasia; Belyaev, Vladimir; Timashev, Peter; Warner, John O; Comberiati, Pasquale; Apfelbacher, Christian; Bezrukov, Evgenii; Politov, Mikhail E; Yavorovskiy, Andrey; Bulanova, Ekaterina; Tsareva, Natalya; Avdeev, Sergey; Kapustina, Valentina A; Pigolkin, Yuri I; Dankwa, Emmanuelle A; Kartsonaki, Christiana; Pritchard, Mark G; Fomin, Victor; Svistunov, Andrey A; Butnaru, Denis; Glybochko, Petr.
  • Munblit D; Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Nekliudov NA; Inflammation, Repair, and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Bugaeva P; Soloviev Research and Clinical Center for Neuropsychiatry, Moscow, Russia.
  • Blyuss O; Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Kislova M; Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Listovskaya E; Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Gamirova A; School of Physics, Astronomy, and Mathematics, University of Hertfordshire, Hatfield, United Kingdom.
  • Shikhaleva A; Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Belyaev V; Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Timashev P; Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Warner JO; Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Comberiati P; Biobank, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Apfelbacher C; Institute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Bezrukov E; Chemistry Department, Lomonosov Moscow State University, Moscow, Russia.
  • Politov ME; Department of Polymers and Composites, N. N. Semenov Institute of Chemical Physics, Moscow, Russia.
  • Yavorovskiy A; Inflammation, Repair, and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Bulanova E; Department of Clinical and Experimental Medicine, Section of Pediatrics, University of Pisa, Pisa, Italy.
  • Tsareva N; Institute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.
  • Avdeev S; Institute for Urology and Reproductive Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Kapustina VA; Department of Intensive Care, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Pigolkin YI; Department of Intensive Care, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Dankwa EA; Department of Intensive Care, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Kartsonaki C; Clinic of Pulmonology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Pritchard MG; Clinic of Pulmonology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Fomin V; Department of Internal Medicine No. 1, Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Svistunov AA; Department of Forensic Medicine, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Butnaru D; Department of Statistics, University of Oxford, Oxford, United Kingdom.
  • Glybochko P; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Clin Infect Dis ; 73(1): 1-11, 2021 07 01.
Article in English | MEDLINE | ID: covidwho-1291240
ABSTRACT

BACKGROUND:

The epidemiology, clinical course, and outcomes of patients with coronavirus disease 2019 (COVID-19) in the Russian population are unknown. Information on the differences between laboratory-confirmed and clinically diagnosed COVID-19 in real-life settings is lacking.

METHODS:

We extracted data from the medical records of adult patients who were consecutively admitted for suspected COVID-19 infection in Moscow between 8 April and 28 May 2020.

RESULTS:

Of the 4261 patients hospitalized for suspected COVID-19, outcomes were available for 3480 patients (median age, 56 years; interquartile range, 45-66). The most common comorbidities were hypertension, obesity, chronic cardiovascular disease, and diabetes. Half of the patients (n = 1728) had a positive reverse transcriptase-polymerase chain reaction (RT-PCR), while 1748 had a negative RT-PCR but had clinical symptoms and characteristic computed tomography signs suggestive of COVID-19. No significant differences in frequency of symptoms, laboratory test results, and risk factors for in-hospital mortality were found between those exclusively clinically diagnosed or with positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RT-PCR. In a multivariable logistic regression model the following were associated with in-hospital mortality older age (per 1-year increase; odds ratio, 1.05; 95% confidence interval, 1.03-1.06), male sex (1.71; 1.24-2.37), chronic kidney disease (2.99; 1.89-4.64), diabetes (2.1; 1.46-2.99), chronic cardiovascular disease (1.78; 1.24-2.57), and dementia (2.73; 1.34-5.47).

CONCLUSIONS:

Age, male sex, and chronic comorbidities were risk factors for in-hospital mortality. The combination of clinical features was sufficient to diagnose COVID-19 infection, indicating that laboratory testing is not critical in real-life clinical practice.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid